Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 3
2008 3
2013 2
2014 3
2015 3
2016 8
2017 5
2018 1
2019 4
2020 4
2021 7
2022 5
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage.
Suárez EU, Piris MÁ, Rodríguez-Pinilla SM, García JF, López-Lorenzo JL, Cornago-Navascués J, Salgado-Sánchez R, Castaño-Bonilla T, Mata-Serna R, Alonso-Domínguez JM, Llamas P. Suárez EU, et al. Among authors: llamas p. Ann Hematol. 2024 May;103(5):1797-1799. doi: 10.1007/s00277-024-05647-6. Epub 2024 Feb 3. Ann Hematol. 2024. PMID: 38308706 No abstract available.
Emergency department management of atrial fibrillation: 2023 consensus from the Spanish Society of Emergency Medicine (SEMES), the Spanish Society of Cardiology (SEC), and the Spanish Society of Thrombosis and Hemostasis (SETH).
Martín A, Calvo D, Llamas P, Roldán V, Cózar R, Fernández de Simón A, Ávila P, Del Arco C, Arbelo E, Piñera P, Coll-Vinent B. Martín A, et al. Among authors: llamas p. Emergencias. 2023 Oct;35(5):359-377. Emergencias. 2023. PMID: 37801418 Free article. English, Spanish.
The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib.
Lahera A, Vela-Martín L, Fernández-Navarro P, Llamas P, López-Lorenzo JL, Cornago J, Santos J, Fernández-Piqueras J, Villa-Morales M. Lahera A, et al. Among authors: llamas p. Mol Carcinog. 2024 Jan;63(1):5-10. doi: 10.1002/mc.23632. Epub 2023 Sep 15. Mol Carcinog. 2024. PMID: 37712558
Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL.
Lahera A, Vela-Martín L, López-Nieva P, Salgado RN, Rodríguez-Perales S, Torres-Ruiz R, López-Lorenzo JL, Cornago J, Llamas P, Fernández-Navarro P, Sánchez-Domínguez R, Segovia JC, Sastre I, Cobos-Fernández MÁ, Menéndez P, Santos J, Fernández-Piqueras J, Villa-Morales M. Lahera A, et al. Among authors: llamas p. Br J Haematol. 2023 Aug;202(3):693-698. doi: 10.1111/bjh.18901. Epub 2023 Jun 2. Br J Haematol. 2023. PMID: 37264982 No abstract available.
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study.
Martínez-López J, De la Cruz J, Gil-Manso R, Alegre A, Ortiz J, Llamas P, Martínez Y, Hernández-Rivas JÁ, González-Gascón I, Benavente C, Estival Monteliu P, Jiménez-Yuste V, Canales M, Bastos M, Kwon M, Valenciano S, Callejas-Charavia M, López-Jiménez J, Herrera P, Duarte R, Núñez Martín-Buitrago L, Sanchez Godoy P, Jacome Yerovi C, Martínez-Barranco P, García Roa M, Escolano Escobar C, Matilla A, Rosado Sierra B, Aláez-Usón MC, Quiroz-Cervantes K, Martínez-Chamorro C, Pérez-Oteyza J, Martos-Martinez R, Herráez R, González-Santillana C, Del Campo JF, Alonso A, de la Fuente A, Pascual A, Bustelos-Rodriguez R, Sebrango A, Ruiz E, Marcheco-Pupo EA, Grande C, Cedillo Á, Lumbreras C, Arroyo Barea A, Casas-Rojo JM, Calbacho M, Diez-Martín JL, García-Suárez J;   Asociación Madrileña de Hematología y Hemoterapia (AMHH). Martínez-López J, et al. Among authors: llamas p. Cancers (Basel). 2023 Feb 27;15(5):1497. doi: 10.3390/cancers15051497. Cancers (Basel). 2023. PMID: 36900296 Free PMC article.
55 results